{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:03:56Z","timestamp":1789898636115,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Research and Development Program","award":["YFC0905001"],"award-info":[{"award-number":["YFC0905001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#81472873"],"award-info":[{"award-number":["#81472873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#81071287"],"award-info":[{"award-number":["#81071287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#31371274"],"award-info":[{"award-number":["#31371274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific and Technological Research in Open Collaborative Projects of Henan Province","award":["#152106000044"],"award-info":[{"award-number":["#152106000044"]}]},{"name":"Shanghai Municipal Commission of Science and Technology Program","award":["#14DJ1400100"],"award-info":[{"award-number":["#14DJ1400100"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.molimm.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T19:28:20Z","timestamp":1546975700000},"page":"170-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Comprehensive assessment of T cell receptor \u03b2 repertoire in Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis patients using high-throughput sequencing"],"prefix":"10.1016","volume":"106","author":[{"given":"Hao","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.01.002_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/cmi.2014.134","article-title":"Alphabeta T cell receptors as predictors of health and disease","volume":"12","author":"Attaf","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0010","doi-asserted-by":"crossref","first-page":"13664","DOI":"10.1038\/srep13664","article-title":"Characteristics of tumor infiltrating lymphocyte and circulating lymphocyte repertoires in pancreatic cancer by the sequencing of T cell receptors","volume":"5","author":"Bai","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2019.01.002_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molimm.2019.01.002_bib0025","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2133.2007.08211.x","article-title":"T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking","volume":"157","author":"Brooklyn","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0030","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/jid.2015.165","article-title":"Oxypurinol-specific T cells possess preferential TCR clonotypes and express granulysin in allopurinol-induced severe cutaneous adverse reactions","volume":"135","author":"Chung","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2018.03.007","article-title":"Characterization of peripheral blood TCR repertoire in patients with ankylosing spondylitis by high-throughput sequencing","author":"Cui","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0040","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2019.01.002_bib0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2249.2008.03763.x","article-title":"Skew in T cell receptor usage with polyclonal expansion in lesions of oral lichen planus without hepatitis C virus infection","volume":"154","author":"Gotoh","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: current understanding","volume":"38","author":"Hoetzenecker","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0060","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jim.2014.01.013","article-title":"In vitro expansion of antigen-specific CD8(+) T cells distorts the T-cell repertoire","volume":"405","author":"Koning","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2019.01.002_bib0070","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0075","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1542\/peds.2008-1923","article-title":"Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis","volume":"123","author":"Levi","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.molimm.2019.01.002_bib0080","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/ncomms3333","article-title":"IMGT\/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2019.01.002_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0090","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2217\/pgs-2017-0090","article-title":"HLA-associated drug hypersensitivity and the prediction of adverse drug reactions","volume":"18","author":"Negrini","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.molimm.2019.01.002_bib0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000083947","article-title":"Novel treatments for drug-induced toxic epidermal necrolysis (Lyell\u2019s syndrome)","volume":"136","author":"Paquet","year":"2005","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tan.13183","article-title":"HLAs: key regulators of T-cell-mediated drug hypersensitivity","volume":"91","author":"Redwood","year":"2018","journal-title":"HLA"},{"key":"10.1016\/j.molimm.2019.01.002_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098611404094","article-title":"Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality","volume":"2","author":"Roujeau","year":"2011","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.molimm.2019.01.002_bib0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molimm.2019.01.002_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/BCR.0b013e31820aafbc","article-title":"Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study","volume":"32","author":"Sekula","year":"2011","journal-title":"J. Burn Care Res."},{"key":"10.1016\/j.molimm.2019.01.002_bib0125","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3279","article-title":"Why must T cells be cross-reactive?","volume":"12","author":"Sewell","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fimmu.2013.00413","article-title":"The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis","volume":"4","author":"Six","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/toxins6010194","article-title":"Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions","volume":"6","author":"Su","year":"2014","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.molimm.2019.01.002_bib0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.molimm.2015.07.012","article-title":"Composition and variation analysis of the TCR beta-chain CDR3 repertoire in systemic lupus erythematosus using high-throughput sequencing","volume":"67","author":"Sui","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0150","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/sji.12614","article-title":"Composition and variation analysis of the T cell receptor beta-chain complementarity determining region 3 repertoire in neonatal Sepsis","volume":"86","author":"Sun","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0155","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/gm502","article-title":"Sequence analysis of T-cell repertoires in health and disease","volume":"5","author":"Woodsworth","year":"2013","journal-title":"Genome Med."},{"key":"10.1016\/j.molimm.2019.01.002_bib0165","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2006.12.617","article-title":"Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity","volume":"119","author":"Wu","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaci.2014.06.025","article-title":"T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome","volume":"135","author":"Wu","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0175","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.1302306","article-title":"Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01","volume":"192","author":"Yun","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.01.002_bib0180","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1097\/BCR.0b013e318254d2ec","article-title":"Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China","volume":"33","author":"Zhu","year":"2012","journal-title":"J. Burn Care Res."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018308071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018308071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T23:42:12Z","timestamp":1565221332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018308071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"alternative-id":["S0161589018308071"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.01.002","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive assessment of T cell receptor \u03b2 repertoire in Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis patients using high-throughput sequencing","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}